Abstract
Sucralfate is a nonabsorbable, nonsystematic agent for the therapy and prevention of peptic ulcer disease. The drug was originally developed in Japan as an agent to deactivate peptic activity. Sucralfate was found to adhere to both ulcerated and normal mucosa with a preference for damaged areas of the gastric mucosa. 1 For these reasons, the original proposals to explain sucralfate’s therapeutic efficacy and its mechanisms of action included both pepsin antagonism and surface adhesion which presumably protect ulcerated areas from luminal acid, enzymes and exogenous damaging agents such as NSAIDs, or alcohol.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bighley L, Giesing D: Mechanism of action studies of sucralfate, in Caspary W (ed): Duodenal Ulcer. Gastric Ulcer: Sucralfale. a New Therapeutic Concept. Munich, Urban &0026; Schwarzenberg, 1981, pp 3–12. Early thoughts as to the mechanisms of action of sucralfate.
Hollander D, Tarnawski A, Gergely H, et al: Sucralfate protection of the gastric mucosa agalnst ethanol-induced injury: A prostaglandin-mediated process? Scan J Gastroenterol 19:97–102, 1984.
Hollander D, Tarnawski A, Krause WJ, et al: The protective effect of sucralfate agalnst alcohol-induced gastric mucosal injury in the rat. Macroscopic, histologic, ultrastructural and functional time sequence analysis. Gastroenterology 88:366–374, 1985.
Tarnawski A, Hollander D, Krause WJ, et al: Does sucralfate affect the normal gastric mucosa? Histologic, ultrastructural and functional assessment. Gastroenterology 90:893–905, 1986.
Tarnawski A, Hollander D, Stachura J, et al: Effect of sucralfate on the normal human gastric mucosa. Endoscopic, histological and ultrastructural assessment. Scand J Gastroenterol 22:111–123, 1987. References 2–5 explored the mechanisms of sucralfate interaction with the normal and ulcerated gastric mucosa and sucralfate’s cytoprotective mechanisms.
Tarnawski A, Hollander D, Stachura J, et al: Prostaglandin protection of the gastric mucosa agalnst alcohol injury, a dynamic time related process. The role of the mucosal proliferative zone. Gastroenterology 89:366–374, 1985.
Tarnawski A, Stachura J, Gergely H, et al: Microvascular endothelium—A major target for alcohol injury of the human gastric mucosa. Histochemical and ultrastructural study. J Clin Gastroenterol 10:53–64, 1988.
Tarnawski A, Stachura J, Hollander D, et al: Cellular aspects of alcohol-induced injury and prostaglandin protection of the human gastric mucosa. Focus on the mucosal microvessels. J Clin Gastroenterol 10:35–45, 1988. References 6–8 represent some of the key experiments regarding the mechanisms of cytoprotective activity of prostaglandins.
Hollander D, Tarnawski A: Gastric Cytoprotection: A Clinician’s Guide. New York, Plenum Press, 1989. A general review of the concept of cytoprotection, its mechanisms, and its clinical applications. This book is directed at both investigators and clinicians.
Szabo S, Brown A: Prevention of ethanol-induced vascular injury and gastric mucosal lesions by sucralfate and its components: Possible role of endogenous sulfhydryls. Proc Soc Exp Biol Med 185:493–497, 1987.
Szabo S, Hollander D: Pathways of gastrointestinal protection and repalr. Am J Med 86(6A):23–31, 1989.
Konturek SJ, Brzozowski T, Bielanski W, et al: Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats. Am J Med 86(6A):32–37, 1989. References 10–12 add other mechanisms to the list of mechanisms of action of sucralfate.
Hollander D: Permeability in Crohn’s disease: Altered barrier functions in healthy relatives? Gastroenterology 104:1848–1851, 1993. A review of the concept of intestinal permeability of larger molecules. Permeability of the gastrointestinal barrier by sucralfate could instigate immunological and reparative reactions in the subepithelial layers and explaln some of sucralfate’s clinical activity.
Hollander D: Integrins: A family of cell surface adhesion receptors—Relevance to intestinal immune defenses. Eur J Gastroenterol Hepatol 5:593–599, 1993. Review of cell surface adhesion molecules of the gastroduodenal mucosa.
Thomson ABR:Helicobacter pylori and gastroduodenal pathology. Can J Gastroenterol 7:353–358, 1993. Recent review of the importance of H. pylori in ulcer disease.
Bianchi Porro G, Hollander D: Treatment of Digestive Disease with Sucralfate. New York, Raven Press, 1989. Review of the mechanisms of action of sucralfate with preliminary data on the possible activity of sucralfate in intestinal inflammation.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Plenum Press
About this chapter
Cite this chapter
Hollander, D. (1995). Future Research into the Mechanisms of Action of Sucralfate. In: Hollander, D., Tytgat, G.N.J. (eds) Sucralfate. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-32154-7_32
Download citation
DOI: https://doi.org/10.1007/978-0-585-32154-7_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44740-2
Online ISBN: 978-0-585-32154-7
eBook Packages: Springer Book Archive